LONDON, Nov. 16, 2004 (PRIMEZONE) -- Smith & Nephew plc (LSE:SN) (NYSE:SNN), the global medical technology business, will tomorrow, 17 November 2004, give a webcast presentation and teleconference on how its UK GAAP results, for 2003 and for the first three quarters of 2004, will be re-stated for comparison purposes when IFRS is adopted from 1 January 2005. This information is being presented to assist the investment community in assessing the impact of IFRS on the group.
The conference call will be held at 2.00pm GMT/9.00am EST. It will be broadcast live on the web at http://www.smith-nephew.com/ifrs and will be available on demand shortly following the close of the conference call at the same web address. If interested parties are unable to connect to the web, a listen-only service is available by calling +44 (0)20 7098 0713 in Europe, and +1 866 602 0258 in the US.
Analysts who wish to participate in the conference call should contact Julie Allen on +44 (0) 20 7960 2254 or via email at julie.allen@smith-nephew.com for conference call details.
About Us
Smith & Nephew (LSE: SN.L; NYSE: SNN) is one of the world's leading medical device companies, specialising in Orthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephew ranks as the global leader in arthroscopy and in advanced wound management and is one of the fastest growing orthopaedics companies in the world.
Smith & Nephew is dedicated to helping improve people's lives. The company prides itself on the strength of its relationships with its surgeon and professional healthcare customers, with whom its name is synonymous with the high standards of performance, innovation and trust. The company has over 8,000 employees and operates in 32 countries around the world, generating sales of nearly GBP1.2 billion.
This information is provided by RNS
The company news service from the London Stock Exchange